---
figid: PMC11354767__ijms-25-08988-g006
figtitle: GPR30 signaling pathway
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11354767
filename: PMC11354767__ijms-25-08988-g006.jpg
figlink: /pmc/articles/PMC11354767/figure/F6
number: F6
caption: GPR30 signaling pathway. (a) The canonical E2 signaling through ER-α and
  the physical interaction of GPR30 with ER-α are represented. Also, the GPR30 activation
  by E2 is shown (b); this receptor has been associated with an inhibitory Gα-protein,
  which impairs the adenylate cyclase activity and, therefore, the CREB nuclear translocation.
  (c) The βγ units trigger the PI3K/AKT pathway and the transactivation of EGFR through
  the release of HB-EGF. These units also activate the MAPK pathway through SRC/SHP2.
  (d) The EGFR and IL-6 signaling crosstalk at the STAT3 level. (e) The GPR30 and
  IL-6 pathways converge at the SHP2 level, resulting in gene expression. (f) The
  GPR30 antagonist G15 impairs the ligand activation of GPR30, and the Pertussis toxin
  (PTX) inhibits the Gαi activation. Created with BioRender.com
papertitle: The GPR30 Receptor Is Involved in IL-6-Induced Metastatic Properties of
  MCF-7 Luminal Breast Cancer Cells
reftext: Ana Carolina Tirado-Garibay, et al. Int J Mol Sci. 2024 Aug;25(16).
year: '2024'
doi: 10.3390/ijms25168988
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: MDPI
keywords: GPR30 | IL-6 | epithelium-mesenchymal transition | luminal | metastasis
automl_pathway: 0.9642279
figid_alias: PMC11354767__F6
figtype: Figure
redirect_from: /figures/PMC11354767__F6
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11354767__ijms-25-08988-g006.html
  '@type': Dataset
  description: GPR30 signaling pathway. (a) The canonical E2 signaling through ER-α
    and the physical interaction of GPR30 with ER-α are represented. Also, the GPR30
    activation by E2 is shown (b); this receptor has been associated with an inhibitory
    Gα-protein, which impairs the adenylate cyclase activity and, therefore, the CREB
    nuclear translocation. (c) The βγ units trigger the PI3K/AKT pathway and the transactivation
    of EGFR through the release of HB-EGF. These units also activate the MAPK pathway
    through SRC/SHP2. (d) The EGFR and IL-6 signaling crosstalk at the STAT3 level.
    (e) The GPR30 and IL-6 pathways converge at the SHP2 level, resulting in gene
    expression. (f) The GPR30 antagonist G15 impairs the ligand activation of GPR30,
    and the Pertussis toxin (PTX) inhibits the Gαi activation. Created with BioRender.com
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - DBT
  - GPER1
  - RBM5
  - AGPAT1
  - MMP1
  - MMP2
  - MMP3
  - MMP7
  - MMP8
  - MMP9
  - MMP10
  - MMP11
  - MMP12
  - MMP13
  - MMP14
  - MMP15
  - MMP16
  - MMP17
  - MMP19
  - MMP20
  - MMP21
  - MMP23B
  - MMP24
  - MMP25
  - MMP26
  - MMP27
  - MMP28
  - SRC
  - FGR
  - FYN
  - YES1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - PTPN11
  - HBEGF
  - GRB2
  - XYLT2
  - SOS1
  - SOS2
  - EGFR
  - ADCY1
  - ADCY2
  - ADCY3
  - ADCY4
  - ADCY5
  - ADCY6
  - ADCY7
  - ADCY8
  - ADCY9
  - ADCY10
  - ATP8A2
  - STAT3
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - NOS3
  - ENO4
  - NFKB1
  - CREB1
  - CREB3
  - CREB5
  - CREB3L1
  - CREB3L2
  - CREB3L3
  - CREB3L4
  - CREM
  - ATF1
  - ATF2
  - EFNB1
  - IL6
  - IL6R
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - MMP
  - ATP
  - CAMP
  - PTX
---
